HIV Diagnosis and the Cascade of Care in Ontario

Slides:



Advertisements
Similar presentations
MINNESOTAS HIV TREATMENT CASCADE. Introduction This slide set describes the continuum of HIV care in Minnesota. The slides rely on data from HIV/AIDS.
Advertisements

Impact of Age and Race on New HIV Infections among Men who have Sex with Men in Los Angeles County Shoshanna Nakelsky, MPH Division of HIV and.
An Introduction to HIV Incidence Surveillance (HIS) in California California Department of Public Health Office of AIDS.
Cascade The Continuum of HIV Care Florida, 2013 Lorene Maddox, MPH Karalee Poschman, MPH Living data through 2013, as of 06/30/2014.
HIV Care Continuum for the United States and Puerto Rico National Center for HIV/AIDS, Viral Hepatitis, STD & TB Prevention Division of HIV/AIDS Prevention.
Illustrating the HIV Care Continuum in U.S. Cities Chicago, IL.
Laboratories Branch, MOHLTC, IMC – 2001 The epidemiology of HIV infection among persons from HIV-endemic countries in Ontario: Update to 2002 Robert S.
Morbidity Monitoring Project Data for Resource Planning and Evaluation A.D. McNaghten Centers for Disease Control and Prevention.
Racial Disparities in Antiretroviral Therapy Use and Viral Suppression among Sexually Active HIV-infected Men who have Sex with Men— United States, Medical.
Wisconsin Department of Health Services HIV/AIDS Surveillance Annual Review New diagnoses, prevalent cases, and deaths through December 31, 2013 April.
Using HIV Surveillance to Achieve High Impact Prevention Irene Hall, PhD, FACE AIDS 2012 High-Impact Prevention: Reducing the HIV Epidemic in the United.
Alliance Discussion with Office of AIDS: November HIV/AIDS Surveillance Surveillance overview HIV Incidence Surveillance Second Surveillance Stakeholder.
HIV and STI Department, Health Protection Agency - Colindale HIV and AIDS Reporting System HIV in the United Kingdom: 2012 Overview.
Epidemiologic overview of HIV/AIDS in Ontario and Toronto: 2004 update Robert S. Remis MD, MPH, FRCPC, Maraki Fikre Merid BSc Ontario HIV Epidemiologic.
HIV Care Continuum, Georgia, United States, 2011 Presented to American Public Health Association, Annual Meeting Presented by Deepali Rane, MBBS, MPH,
The WHO HIV Drug Resistance Strategy Presented by Dr. Don Sutherland Prepared by: Dr. Don Sutherland Dr Silvia Bertagnolio Dr Diane Bennett HIV Drug Resistance.
HIV Care Continuum New Diagnoses, 2011, Fulton County, Georgia.
HIV Care Continuum, District 10 Northeast (Athens), Georgia, 2012.
Monitoring Indicators of the National HIV/AIDS Strategy Using Data for Public Health Action Irene Hall, PhD, FACE HIV Incidence and Case Surveillance Branch.
HIV Care Continuum Persons Living With HIV, Georgia, 2012.
HIV infection among persons in Ontario infected through heterosexual contact Robert S. Remis, Maraki Fikre Merid Ontario HIV Epidemiologic Monitoring Unit.
Recent Epidemiologic Situations of TB in Myanmar -Preliminary Review of Data from routine TB surveillance focusing on Case Finding- 9 May 2014, Nay Pyi.
Trends in HIV diagnoses in Ontario, 2000­2004 Robert S. Remis, Jane Njihia, Carol Swantee, Maraki Fikre Merid Ontario HIV Epidemiologic Monitoring Unit,
Understanding temporal trends in HIV prevalence, incidence and ARV Dr Valerie Delpech Head of HIV surveillance Public Health England.
Epidemiologic trends in HIV infection among men who have sex with men in Ontario: The situation in 2004 Robert S. Remis, Maraki Fikre Merid Ontario HIV.
HIV and STI Department, Health Protection Agency - Colindale HIV and AIDS Reporting System The threshold for an ART secondary prevention effect on HIV.
The Continuum of HIV Care Florida, 2014 The Continuum of HIV Care Florida, 2014 Lorene Maddox, MPH Karalee Poschman, MPH Living data through 2014, as of.
Annual Epidemiological Spotlight on HIV in London: 2014 data Field Epidemiology Services PHE Publications gateway number
MINNESOTA’S HIV TREATMENT CASCADE April, Introduction.
Mean HIV viral load among resident cases and undiagnosed in Oregon Jeff Capizzi, Epidemiologist Sean Schafer, HIV/STD/TB Medical Epidemiologist Lea Bush,
The HIV epidemic in Ontario: 2004 update Robert S. Remis, MD, MPH, FRCPC Ontario HIV Epidemiologic Monitoring Unit Department of Public Health Sciences,
HIV Care Continuum New Diagnoses, 2011, Georgia. Persons with HIV Engaged in Selected Stages of the Continuum of Care, United States Percent
Marked increase in first-time HIV diagnoses in Ontario, 2002.
Wisconsin Department of Health Services CDC and HRSA released guidance on June 19, 2015 Guidance for health departments and planning groups Development.
Improving health worldwide Implications for Monitoring of the HIV Care Cascade? Jim Todd MeSH Satellite Session IAS Durban, Monday 18 th.
The HIV epidemic in Ontario: An epidemiologic update Robert S. Remis, MD, MPH, FRCPC, Department of Public Health Sciences, University of Toronto Presentation.
Update on epidemiology of HIV in New Zealand Dr Sue McAllister AIDS Epidemiology Group (AEG) University of Otago Dunedin HIV Women’s Seminar Auckland,
State Office of AIDS Update
Virginia Macdonald, Annette Verster
Men are absent across the HIV continuum of care in a rural area of southern Mozambique Laura Fuente-Soro, Elisa Lopez-Varela, Orvalho Augusto , Charfudin.
Illustrating the HIV Care Continuum in U.S. Cities
Illustrating the HIV Care Continuum in U.S. Cities
Zimbabwe’s shift towards treat all: national country context
HIV Epidemiological Profile for Chicago EMA
Lung cancer prevalence on the rise (Nov. 2014)
HIV Care Continuum in Manhattan
Illustrating the HIV Care Continuum in U.S. Cities
Cost of Screening Outside of IPP Chlamydia Screening Guidelines
Adolescents (10-19 yr) Last updated: October 2017.
Illustrating the HIV Care Continuum in U.S. Cities
Epidemiologic trends in HIV infection among men who have sex with men in Ontario: The situation in 2003 Robert S. Remis, Maraki Fikre Merid Ontario HIV.
HIV/AIDS Surveillance in Europe 2011 HIV/AIDS Surveillance in Europe
AIDS Trends   For all slides in this series, the following notes apply:
Epidemiologic Update on the HIV Epidemic in Ontario
Hidden Opportunities - What Will It Take to Reach in Eastern Europe?
3rd Annual Health Policy Conference – Ryerson University
Illustrating the HIV Care Continuum in U.S. Cities
Needs Assessment Slides for Module 4
Summary Sheet Figures and Maps
Summary Sheet Figures and Maps
Summary Sheet Figures and Maps
Epidemiology of HIV Infection, through 2011.
Summary Sheet Figures and Maps
Summary Sheet Figures and Maps
Summary Sheet Figures and Maps
HIV in Minnesota: Challenges and Opportunities
Summary Sheet Figures and Maps
TRACE INITIATIVE: Overview
Japan Last updated: April 2019.
HIV Recency Testing in Rwanda
Presentation transcript:

HIV Diagnosis and the Cascade of Care in Ontario Abigail Kroch, Ph.D. M.P.H. Director of the Applied Epidemiology Unit Ontario HIV Treatment Network June 2017

What is the Ontario HIV Epidemiology and Surveillance Initiative (OHESI)? A new collaboration What do we hope to achieve? Better access to timely, relevant and comprehensive information about the epidemiology of HIV in Ontario Disseminate this information more widely to the stakeholders who need to know it

Lab Testing Data Person decides to get an HIV test Health care provider completes a lab form (known as a test requisition) Specimen is collected and sent to Public Health Ontario Laboratory If the result is HIV positive: Result reported back to health care provider to give result to the person, and to local public health unit Result is shared with the Laboratory Enhancement Program (LEP), which sends a data collection form to the health care provider

Changes to the Test Requisition in 2017 Simplified Exposure Categories Expanded Reasons for Testing Expanded sex/gender categories to include M-F and F-M transgender.

Cascade of care, testing and diagnosis Diagnostic Testing (Public Health Ontario Laboratory data)

Number of HIV tests, total, Ontario, 2000-2015 Key points There was a large increase in the number of tests between 2000 and 2006, which stabilized in the late 2000s. Since 2010, there has been a slight but steady increase in number of tests. Limitations Tests conducted prenatally are not included. OHESI is a collaboration between the AIDS Bureau of the Ontario Ministry of Health and Long-Term Care, Public Health Ontario, Public Health Agency of Canada, and the Ontario HIV Treatment Network (OHTN). The main objective of OHESI is to understand, monitor and translate the epidemiology of HIV in the province of Ontario. Data provided to Ontario HIV Epidemiology and Surveillance Initiative (OHESI) by Public Health Ontario Laboratory. Does not include prenatal tests. www.ohesi.ca

Positivity rate, total and by sex, Ontario, 2000-2015 Key points The positivity rate has steadily decreased overall and for both sexes since 2000 The positivity rate has consistently been higher for males compared to females. Limitations Tests conducted prenatally are not included. HIV test positivity rates can be helpful by indicating which populations of individuals testing for HIV have a higher level of HIV risk. However, positivity rates should be interpreted with caution as they are influenced by both changes in HIV incidence as well as changes in the number and types of people getting tested and it is difficult to disentangle these two effects. OHESI is a collaboration between the AIDS Bureau of the Ontario Ministry of Health and Long-Term Care, Public Health Ontario, Public Health Agency of Canada, and the Ontario HIV Treatment Network (OHTN). The main objective of OHESI is to understand, monitor and translate the epidemiology of HIV in the province of Ontario. Data provided to Ontario HIV Epidemiology and Surveillance Initiative (OHESI) by Public Health Ontario Laboratory. Does not include prenatal tests. Positivity rate is the proportion of tests with HIV-positive results. www.ohesi.ca

HIV Positivity rate by exposure category, Ontario, 2014-2015 Data provided to OHESI by PHOL

Number of tests and HIV Positivity rate by age and sex, Ontario, 2013-2015 Data provided to OHESI by PHOL

New HIV diagnoses, total, Ontario, 2007-2016 Key points The number of new HIV diagnoses has generally decreased over the past decade. There has been a slight increasing trend since 2013. This increase does not necessarily mean that HIV infections are increasing, and may partly be due to increased HIV testing during this time. There were 842 new HIV diagnoses in 2015, which was slightly higher than the 828 diagnoses in 2014. The number of diagnoses in 2015 was still lower than most years over the past decade. Data provided to Ontario HIV Epidemiology and Surveillance Initiative (OHESI) by Public Health Ontario Laboratory. www.ohesi.ca

New HIV diagnoses by sex, Ontario, 2007-2016 Key Points There was a slight increase in male diagnoses from 2014 (655) to 2015. The percent female diagnoses have generally decreased over the past decade Data provided to Ontario HIV Epidemiology and Surveillance Initiative (OHESI) by Public Health Ontario Laboratory. www.ohesi.ca

New HIV diagnoses by age and sex, Ontario, 2016 Key Points There was a slight increase in male diagnoses from 2014 (655) to 2015. The percent female diagnoses have generally decreased over the past decade Data provided to Ontario HIV Epidemiology and Surveillance Initiative (OHESI) by Public Health Ontario Laboratory. www.ohesi.ca

New HIV diagnoses by Health Region, Ontario, 2016 Key Points There was a slight increase in male diagnoses from 2014 (655) to 2015. The percent female diagnoses have generally decreased over the past decade Data provided to Ontario HIV Epidemiology and Surveillance Initiative (OHESI) by Public Health Ontario Laboratory. www.ohesi.ca

Ontario’s HIV Prevention, Engagement, and Care Cascade Diagnostic and Viral Load Testing (Public Health Ontario Laboratory data)

Cascade indicators Ontario cascade steps defined based on review of the literature, OHESI Technical Working Group decisions, and expert consultation We calculated the number of individuals each year meeting the cascade indicator definitions The denominator used to calculate the proportion of individuals in each stage per year varied by cascade stage Each indicator has a “Main” estimate, representing our best estimate for the cohort Where applicable, also calculated “Upper” and “Lower” estimates based on a sensitivity analysis of our assumptions

Number of people with diagnosed HIV living in Ontario, 2000-2015 17,423 16,111 Data provided to OHESI by the Public Health Ontario Laboratory

Proportion of diagnosed PLWH who are in care, Ontario, 2000-2015 Data provided to OHESI by the Public Health Ontario Laboratory

Proportion of diagnosed PLWH who are on treatment, Ontario, 2000-2015 82.0% 69.9% Data provided to OHESI by the Public Health Ontario Laboratory -- Poster #: EPHP1.03 – CAHR April 2017

Proportion of diagnosed PLWH on treatment who are virally suppressed, Ontario, 2000-2015 95.1% 90.9% Data provided to OHESI by the Public Health Ontario Laboratory – CAHR Poster #: EPHP1.03 – CAHR April 2017

Time from diagnosis to viral load suppression, Ontario, 2000-2013 Data provided to OHESI by PHOL

Proportion of diagnosed PLWH engaged in the HIV cascade, Ontario, 2000-2015 Data provided to OHESI by PHOL

UNAIDS 90-90-90 Targets Source: www.avert.org If all UNAIDS targets are met, this would mean… 90% of all people living with HIV are diagnosed 81% of all people living with HIV are on treatment 73% of all people living with HIV are virally suppressed

Where is Ontario with the 90-90-90? 81% 66% 62% Data provided to OHESI by the Public Health Ontario Laboratory – CAHR April 2017

Take-Home Messages Most comprehensive province-wide estimates of the HIV cascade for Ontario Engagement in Ontario’s HIV cascade has improved over time Reflects success of care and treatment initiatives, availability of improved antiretroviral treatment regimens, and guideline changes A full understanding of how close Ontario is to the combined 90-90-90 target (all PLWH  90% diagnosed, 81% on ART, and 73% virally suppressed) requires a reliable estimate of the First 90

Improving Ontario’s cascade Generate estimates by age, sex, population and region Link to administrative health record databases at ICES to better account for migration and death Develop Ontario models for HIV incidence, prevalence and undiagnosed infection Improve missing data through modelling and improved data quality

Acknowledgements OHESI partners Technical working group Public Health Ontario (PHO) AIDS Bureau, Ministry of Health and Long-Term Care Public Health Agency of Canada (PHAC) Ontario HIV Treatment Network (OHTN) Technical working group Juan Liu (PHO Laboratory) Ashleigh Sullivan (PHO Laboratory) Lucia Light (OTHN) Beth Rachlis (OHTN) James Wilton (OHTN) Claudia Rank (PHAC) Steering Committee Champions Committee

For more information or to register for updates, please visit www For more information or to register for updates, please visit www.ohesi.ca akroch@ohtn.on.ca